Open Beta
TREN
MetriLume
TREN

US marketsFENC

SEC-sourced researchBeta

FENC

FENNEC PHARMACEUTICALS INC.

Company comparison ↗

Data passport

CIK
0001211583
Exchange
Nasdaq
Business activity
— · SIC 2836
Financial inputs
6/6
Filing date
Oct 1, 2026
SEC registry record
Operating company
Last updated: SEC company ticker catalog ↗SEC Financial Statement Data Sets ↗SEC investment company series and class registry ↗

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2024: 47,538,000.0000 USD; December 2025: 44,642,000.0000 USD47.5M USD0 USD0December 2024December 2025
FENC · Exact amounts and source periods · USD
Period endRevenueFiling date
December 202447,538,000.0000Mar 27, 2026
December 202544,642,000.0000Mar 27, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 202544,642,000.0000-9,741,000.0000-12,473,000.000070,551,000.000035,079,000.0000Mar 27, 2026
December 202447,538,000.0000-436,000.000026,980,000.000044,946,000.000050,818,000.0000Mar 27, 2026

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenues$44.64MDecember 2025Mar 27, 202610-K
Previous period revenueRevenues$47.54MDecember 2024Mar 27, 202610-K
Net incomeNetIncomeLoss-$9.74MDecember 2025Mar 27, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities-$12.47MDecember 2025Mar 27, 202610-K
Total assetsAssets$70.55MDecember 2025Mar 27, 202610-K
Total liabilitiesLiabilities$35.08MDecember 2025Mar 27, 202610-K

New filings

Explore methodology ↗